184 related articles for article (PubMed ID: 38714484)
1. Trial characteristics and treatment effect estimates in randomized controlled trials of Chinese herbal medicine: A meta-epidemiological study.
Wang BH; Lin YL; Gao YY; Song JL; Qin L; Li LQ; Liu WQ; Zhong CCW; Jiang MY; Mao C; Yang XB; Chung VCH; Wu IXY
J Integr Med; 2024 May; 22(3):223-234. PubMed ID: 38714484
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials.
Anglemyer A; Horvath HT; Bero L
Cochrane Database Syst Rev; 2014 Apr; 2014(4):MR000034. PubMed ID: 24782322
[TBL] [Abstract][Full Text] [Related]
4. [Chinese herbal medicine for side effects of transarterial chemoembolization in liver cancer patients: a systematic review and meta-analysis].
Li XQ; Ling CQ
Zhong Xi Yi Jie He Xue Bao; 2012 Dec; 10(12):1341-62. PubMed ID: 23257126
[TBL] [Abstract][Full Text] [Related]
5. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials: a meta-epidemiological study.
Toews I; Anglemyer A; Nyirenda JL; Alsaid D; Balduzzi S; Grummich K; Schwingshackl L; Bero L
Cochrane Database Syst Rev; 2024 Jan; 1(1):MR000034. PubMed ID: 38174786
[TBL] [Abstract][Full Text] [Related]
6. Empirical Evidence of Study Design Biases in Randomized Trials: Systematic Review of Meta-Epidemiological Studies.
Page MJ; Higgins JP; Clayton G; Sterne JA; Hróbjartsson A; Savović J
PLoS One; 2016; 11(7):e0159267. PubMed ID: 27398997
[TBL] [Abstract][Full Text] [Related]
7. Clinical evidence of three traditional Chinese medicine drugs and three herbal formulas for COVID-19: A systematic review and meta-analysis of the Chinese population.
You LZ; Dai QQ; Zhong XY; Yu DD; Cui HR; Kong YF; Zhao MZ; Zhang XY; Xu QQ; Guan ZY; Wei XX; Zhang XC; Han SJ; Liu WJ; Chen Z; Zhang XY; Zhao C; Jin YH; Shang HC
J Integr Med; 2023 Sep; 21(5):441-454. PubMed ID: 37596131
[TBL] [Abstract][Full Text] [Related]
8. Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study.
Dechartres A; Boutron I; Trinquart L; Charles P; Ravaud P
Ann Intern Med; 2011 Jul; 155(1):39-51. PubMed ID: 21727292
[TBL] [Abstract][Full Text] [Related]
9. Chinese herbal medicine for COVID-19: Current evidence with systematic review and meta-analysis.
Fan AY; Gu S; Alemi SF;
J Integr Med; 2020 Sep; 18(5):385-394. PubMed ID: 32792254
[TBL] [Abstract][Full Text] [Related]
10. The relationship of publication language, study population, risk of bias, and treatment effects in acupuncture related systematic reviews: a meta-epidemiologic study.
Li J; Hui X; Yao L; Shi A; Yan P; Yao Y; Wang Q; Ma Y; Wei D; Lan L; Chen L; Yan L; Fang F; Li H; Feng X; Wu J; Qiao Y; Zhang W; Esill J; Qiao C; Yang K
BMC Med Res Methodol; 2023 Apr; 23(1):96. PubMed ID: 37081403
[TBL] [Abstract][Full Text] [Related]
11. Empirical evidence of study design biases in nutrition randomised controlled trials: a meta-epidemiological study.
Stadelmaier J; Roux I; Petropoulou M; Schwingshackl L
BMC Med; 2022 Oct; 20(1):330. PubMed ID: 36217133
[TBL] [Abstract][Full Text] [Related]
12. Chinese herbal medicine Ginkgo biloba L. preparations for ischemic stroke: An overview of systematic reviews and meta-analyses.
Meng TT; You YP; Li M; Guo JB; Song XB; Ding JY; Xie XL; Li AQ; Li SJ; Yin XJ; Wang P; Wang Z; Wang BL; He QY
J Integr Med; 2024 Mar; 22(2):163-179. PubMed ID: 38519277
[TBL] [Abstract][Full Text] [Related]
13. Chinese herbal medicine for subfertile women with polycystic ovarian syndrome.
Zhou K; Zhang J; Xu L; Lim CED
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD007535. PubMed ID: 34085287
[TBL] [Abstract][Full Text] [Related]
14. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies.
Savović J; Jones H; Altman D; Harris R; Jűni P; Pildal J; Als-Nielsen B; Balk E; Gluud C; Gluud L; Ioannidis J; Schulz K; Beynon R; Welton N; Wood L; Moher D; Deeks J; Sterne J
Health Technol Assess; 2012 Sep; 16(35):1-82. PubMed ID: 22989478
[TBL] [Abstract][Full Text] [Related]
15. Chinese herbal medicine for subfertile women with polycystic ovarian syndrome.
Zhou K; Zhang J; Xu L; Wu T; Lim CE
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD007535. PubMed ID: 27731904
[TBL] [Abstract][Full Text] [Related]
16. Chinese herbal medicine for endometriosis.
Flower A; Liu JP; Lewith G; Little P; Li Q
Cochrane Database Syst Rev; 2012 May; (5):CD006568. PubMed ID: 22592712
[TBL] [Abstract][Full Text] [Related]
17. Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions.
Page MJ; McKenzie JE; Kirkham J; Dwan K; Kramer S; Green S; Forbes A
Cochrane Database Syst Rev; 2014 Oct; 2014(10):MR000035. PubMed ID: 25271098
[TBL] [Abstract][Full Text] [Related]
18. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
19. The Efficacy and Safety of Chinese Herbal Medicine in the Treatment of Knee Osteoarthritis: An Updated Systematic Review and Meta-Analysis of 56 Randomized Controlled Trials.
Lin Z; Zheng J; Chen M; Chen J; Lin J
Oxid Med Cell Longev; 2022; 2022():6887988. PubMed ID: 35035664
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Chinese Herbal Medicine for Knee Osteoarthritis: Systematic Review and Meta-analysis of Randomized Controlled Trials.
Liang Y; Xu Y; Zhu Y; Ye H; Wang Q; Xu G
Phytomedicine; 2022 Jun; 100():154029. PubMed ID: 35316726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
